Correction of phenotype misclassification based on high-discrimination genetic predictive risk models.
暂无分享,去创建一个
[1] Johanna M Seddon,et al. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. , 2011, Ophthalmology.
[2] John P A Ioannidis,et al. Predicting death: an empirical evaluation of predictive tools for mortality. , 2011, Archives of internal medicine.
[3] Aaron Y. Lee,et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration , 2011, Human molecular genetics.
[4] D. Goldstein,et al. Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection. , 2011, American journal of epidemiology.
[5] J. Ioannidis,et al. Strengthening the reporting of genetic risk prediction studies: the GRIPS statement , 2011, Genetics in Medicine.
[6] Bjarni V. Halldórsson,et al. Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22 , 2010, Annals of the rheumatic diseases.
[7] Robert H Lyles,et al. Sensitivity analysis for misclassification in logistic regression via likelihood methods and predictive value weighting , 2010, Statistics in medicine.
[8] Ming D. Li,et al. Genome-wide meta-analyses identify multiple loci associated with smoking behavior , 2010, Nature Genetics.
[9] John P A Ioannidis,et al. What makes a good predictor?: the evidence applied to coronary artery calcium score. , 2010, JAMA.
[10] Aaron Y. Lee,et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.
[11] Margaret A. Pericak-Vance,et al. Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.
[12] D. Bild,et al. Score What Makes a Good Predictor ? : The Evidence Applied to Coronary Artery Calcium , 2010 .
[13] J. Ioannidis,et al. Assessment of claims of improved prediction beyond the Framingham risk score. , 2009, JAMA.
[14] D. S. Parker,et al. Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence , 2009, Neuroscience.
[15] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[16] John P. A. Ioannidis,et al. Validating, augmenting and refining genome-wide association signals , 2009, Nature Reviews Genetics.
[17] D G Altman,et al. Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond , 2009, British Journal of Cancer.
[18] E. Souied,et al. [Epidemiology of age related macular degeneration]. , 2009, Journal Francais d'Ophtalmologie.
[19] A. Paterson,et al. Phenotype definition and development—contributions from Group 7 , 2009, Genetic epidemiology.
[20] T. Hansen,et al. Genotype-Phenotype Associations in Obesity Dependent on Definition of the Obesity Phenotype , 2008, Obesity Facts.
[21] M. Wojczynski,et al. Definition of phenotype. , 2008, Advances in genetics.
[22] Johanna M Seddon,et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration , 2007, Nature Genetics.
[23] Laurence Freedman. Quantitative science methods for biomarker validation in chemoprevention trials. , 2007, Cancer biomarkers : section A of Disease markers.
[24] Chi Pui Pang,et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. , 2007, Science.
[25] P. Chyou. Patterns of bias due to differential misclassification by case–control status in a case–control study , 2007, European Journal of Epidemiology.
[26] Johanna M Seddon,et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.
[27] Timothy L Lash,et al. A method to automate probabilistic sensitivity analyses of misclassified binary variables. , 2005, International journal of epidemiology.
[28] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[29] Gang Zheng,et al. The impact of diagnostic error on testing genetic association in case–control studies , 2005, Statistics in medicine.
[30] Sander Greenland,et al. Multiple‐bias modelling for analysis of observational data , 2005 .
[31] S. Faraone,et al. Identification of the phenotype in psychiatric genetics , 2005, European Archives of Psychiatry and Clinical Neuroscience.
[32] Chad Haynes,et al. Power and sample size calculations in the presence of phenotype errors for case/control genetic association studies , 2005, BMC Genetics.
[33] G. Molenberghs,et al. A perspective on surrogate endpoints in controlled clinical trials , 2004, Statistical methods in medical research.
[34] R J Carroll,et al. On meta-analytic assessment of surrogate outcomes. , 2000, Biostatistics.
[35] D G Altman,et al. What do we mean by validating a prognostic model? , 2000, Statistics in medicine.
[36] S D Walter,et al. Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. , 1988, Journal of clinical epidemiology.
[37] P A Lachenbruch,et al. Effects of misclassifications on statistical inferences in epidemiology. , 1980, American journal of epidemiology.
[38] H Checkoway,et al. Bias due to misclassification in the estimation of relative risk. , 1977, American journal of epidemiology.